-
Published on Aug 25, 2016
Instem PLC (LON:INS) chief executive Phil Reason tells Proactive Investors
that the company wants to “dominate” niche markets after it announced a
solid first six months of trading in 2016.
“We think we can do as we do in many other areas of our business and be a market leader in a particular niche,” Reason says.
“We have some particular areas where we think we can dominate some of those niches.”
Reason adds that the biotech industry, the company’s main market, has been “buoyant” for the last couple of years and he expects it to remain that way for the foreseeable future.
“The contact research organisations that make up a lot of our client base today, their facilities are generally full as they conduct probably the largest numbers of studies they’ve ever enjoyed.”
http://www.4-traders.com/INSTEM-PLC-6727729/
No comments:
Post a Comment